FDA Inspection 1305576 — Magesh Rajagopal, MBBS
The FDA completed an inspection of Magesh Rajagopal, MBBS on February 7, 2026 in Tiruchirappalli. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tiruchirappalli (India)
Additional Details
Clinical BA/BE